// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A transition evening is a popular and effective way to deliver high quality transition in respiratory paediatrics

Alison Scott - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Baseline FeNO is an independent predictive marker of Exercise-Induced Bronchoconstriction (EIB)

Matteo Bonini - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Mofezolac

Pneumothorax induction with a Boutin needle without ultrasound guidance during local anaesthetic thoracoscopy.

Mark Watson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pneumothorax

Lidocaine

Singing for Lung Health: Evaluation of the British Lung Foundation programme.

Adam Lewis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Individualised dietary treatment of congenital chylothorax

Louisa Whitfield-Brown - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - The population attributable risks (PAR) for chronic airflow obstruction (CAO) in 40 BOLD study centres worldwide.

Peter Burney - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A new score to identify patients who need fitness to fly test

Giulia Spoletini - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Airway smooth muscle mass reduction after Bronchial Thermoplasty in asthmatics correlates with FEV1.

Julia N.S. D'Hooghe - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dermatan sulfate

Cost variations of asthma over 10 years in adults

Laura Portas - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Extrafine glycopyrronium bromide (GB) in addition to extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FF) in uncontrolled asthmatic patients

Dave Singh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

beclomethasone dipropionate/formoterol (NEXT DPI)

Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study

Namhee Kwon - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Mepolizumab

Does simplified Well’s score combined with age-adjusted d-dimer reduce inappropriate CT pulmonary angiogram and incidence of contrast induced nephropathy?

Asim Ahmed - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Contrast-induced Acute Kidney Injury

N/A

The Pulmonary Passport: Uptake of a regional electronic procedure logbook in Respiratory Medicine

Maryam Ahmed - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

How do forehead and finger sensors align to capillary oxygen saturation during the six minute walk test?

Lucy Robertson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia

Vadsala Baskaran - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Quality Improvement: Implementing NEWS scores at morning board round to improve discussion of sick respiratory patients

Kamatamu Amanda Mbonye - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Temporal trends in the initiation of domiciliary non-invasive ventilation (NIV)

Alana Livesey - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Earlier use of fractional exhaled Nitric Oxide (FeNO) and challenge testing improves speed and accuracy of asthma diagnosis. MacLeod J, Respiratory Physiology, Bradshaw TA, Respiratory Medicine, Royal Infirmary of Edinburgh

Jill MacLeod - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Features of adult-onset (19+) difficult asthma differ by sex in the WATCH cohort.

Clair Barber - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Assessing breathlessness following pleural fluid drainage using the Visual Analogue Scale for Dyspnoea(VASD) over 1 week(7-DVQ)

Radhika Banka - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved